Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per c...

FDA Drug Recall #D-0070-2023 — Class III — November 14, 2022

Recall Summary

Recall Number D-0070-2023
Classification Class III — Low risk
Date Initiated November 14, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Acella Pharmaceuticals, LLC
Location Alpharetta, GA
Product Type Drugs
Quantity 637 cartons

Product Description

Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

Reason for Recall

Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

Distribution Pattern

Nationwide in the USA.

Lot / Code Information

Lot: E026A001 Exp. 06/2023

Other Recalls from Acella Pharmaceuticals, LLC

Recall # Classification Product Date
D-0014-2026 Class II Doxycycline Hyclate Tablets, USP 100 mg*, 500-c... Sep 29, 2025
D-0490-2024 Class III Sodium Sulfacetamide 10% - Sulfur 5% Cleanser, ... Apr 24, 2024
D-0074-2023 Class III Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pa... Nov 14, 2022
D-0069-2023 Class III Phenytoin Sodium Injection, USP 100 mg/2 mL, ND... Nov 14, 2022
D-0397-2021 Class I NP Thyroid 60 Thyroid Tablets, USP 1 grain (60 ... Apr 29, 2021

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.